Co-Authors
This is a "connection" page, showing publications co-authored by Ruchong Chen and Shiyue Li.
Connection Strength
3.881
-
Response. Chest. 2020 12; 158(6):2700-2701.
Score: 0.916
-
Impaired pulmonary function in discharged patients with COVID-19: more work ahead. Eur Respir J. 2020 07; 56(1).
Score: 0.894
-
The use of non-invasive ventilation in COVID-19: A systematic review. Int J Infect Dis. 2021 May; 106:254-261.
Score: 0.234
-
Clinical Features of Coronavirus Disease 2019 Patients With Mechanical Ventilation: A Nationwide Study in China. Crit Care Med. 2020 09; 48(9):e809-e812.
Score: 0.225
-
Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020 Jun; 55(6).
Score: 0.222
-
Serum amyloid A is a predictor for prognosis of COVID-19. Respirology. 2020 07; 25(7):764-765.
Score: 0.220
-
Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol. 2020 Jul; 146(1):89-100.
Score: 0.220
-
Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China. Chest. 2020 07; 158(1):97-105.
Score: 0.219
-
Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. Lancet Haematol. 2020 05; 7(5):e362-e363.
Score: 0.219
-
Critical Review of the Scientific Evidence and Recommendations in COVID-19 Management Guidelines. Open Forum Infect Dis. 2021 Aug; 8(8):ofab376.
Score: 0.060
-
Earlier diagnosis improves COVID-19 prognosis: a nationwide retrospective cohort analysis. Ann Transl Med. 2021 Jun; 9(11):941.
Score: 0.059
-
Predictors of fatal outcomes among hospitalized COVID-19 patients with pre-existing hypertension in China. Clin Respir J. 2021 Aug; 15(8):915-924.
Score: 0.059
-
Cardiopulmonary exercise testing might be helpful for interpretation of impaired pulmonary function in recovered COVID-19 patients. Eur Respir J. 2021 01; 57(1).
Score: 0.058
-
Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China. Eur Respir J. 2020 06; 55(6).
Score: 0.055
-
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020 05; 55(5).
Score: 0.055
-
Clinical characteristics of COVID-19 infection in chronic obstructive pulmonary disease: a multicenter, retrospective, observational study. J Thorac Dis. 2020 May; 12(5):1811-1823.
Score: 0.055
-
Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 04 30; 382(18):1708-1720.
Score: 0.054
-
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020 03; 21(3):335-337.
Score: 0.054